Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

N-chlorotaurine

Next Previous
X
Search
Drug Profile

N-chlorotaurine

Alternative Names: ACU-NCT-001; ATV-02; N-chlorotaurine - Manhattan Pharmaceuticals; NCT - Pathogenics

Latest Information Update: 21 Apr 2011

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Innsbruck
  • Developer Medical University of Vienna; OPKO Health; Pathogenics
  • Class Alkanesulfonic acids; Antibacterials; Antifungals
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Acanthamoeba infections; Infectious conjunctivitis; Otitis externa; Sinusitis; Skin ulcer

Most Recent Events

  • 25 Feb 2008 Antimicrobial data from a preclinical trial in acanthamoeba infections released by OPKO Health and Pathogenics Inc.
  • 12 Jul 2007 Opko Corporation is now called Opko Health
  • 27 Mar 2007 eXegenics has merged with Acuity Pharmaceuticals to form Opko Corporation

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top